A new blood test has been developed to screen for disease Z. Researchers establish 50 units as a cut point above which a test is considered positive and thereby indicative of disease. The test manufacturers determine that the test's sensitivity is unacceptably low. However, the manufacturers are not concerned with the specificity and do not want the cost of the test to rise. How can they improve the sensitivity of the test?